Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Receivables - Net: 2024

Historic Receivables - Net for Gossamer Bio (GOSS) over the last 1 years, with Dec 2024 value amounting to $5.3 million.

  • Gossamer Bio's Receivables - Net rose 40.30% to $9.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.2 million, marking a year-over-year increase of 40.30%. This contributed to the annual value of $5.3 million for FY2024, which is N/A change from last year.
  • Latest data reveals that Gossamer Bio reported Receivables - Net of $5.3 million as of FY2024.
  • In the past 5 years, Gossamer Bio's Receivables - Net ranged from a high of $5.3 million in FY2024 and a low of $5.3 million during FY2024.
  • Over the past 1 years, Gossamer Bio's median Receivables - Net value was $5.3 million (recorded in 2024), while the average stood at $5.3 million.